Shendelman Shoshana

President and CEO at Applied Therapeutics, Inc.

Sold, on record
$15M
Dollars the filings state
Form 4 sales
9
Latest Aug 14, 2024
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Applied Therapeutics, Inc.Plan not stated
    Jul 22 2020

    Sold 45,000 shares at $26.68 ($1.2M)

    Shendelman Shoshana, President and CEO

    Sold 7.5% of holdings ($16M position)554,285 shares leftFiling

  2. 2 Form 4 sale Applied Therapeutics, Inc.Plan not stated
    Jan 11 +903 days

    Sold 15,870 shares at $0.91 ($14k)

    Shendelman Shoshana, President and CEO

    Sold 2.1% of holdings ($698k position)751,625 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale Applied Therapeutics, Inc.No plan
    Sep 27 +259 days

    Sold 115,632 shares at $2.70 ($312k)

    Shendelman Shoshana, President and CEO

    No 10b5-1 planSold 4.3% of holdings ($7.3M position)2.6M shares leftFiling

  4. 4 Form 4 sale Applied Therapeutics, Inc.No plan
    Nov 30 +64 days

    Sold 3,968 shares at $1.97 ($8k)

    Shendelman Shoshana, President and CEO

    No 10b5-1 planSold 0.2% of holdings ($5.1M position)2.6M shares leftFiling

  5. 5 Form 4 sale Applied Therapeutics, Inc.Unusual
    Mar 14 +105 days

    Sold 318,573 shares at $5.39 ($1.7M)

    Shendelman Shoshana, President and CEO

    No 10b5-1 planSold 7.7% of holdings ($22.3M position)3.8M shares left20.1x usual sizeFiling

  6. 6 Form 4 sale Applied Therapeutics, Inc.No plan
    Jun 6 +84 days

    Sold 61,795 shares at $4.32 ($267k)

    Shendelman Shoshana, President and CEO

    No 10b5-1 planSold 1.6% of holdings ($16.5M position)3.8M shares left0.9x usual sizeFiling

  7. 7 Form 144 notice Applied Therapeutics, Inc.Notice
    Aug 9 +64 days

    Filed to sell 1M shares ($6.2M)

    Shendelman Shoshana, Officer, President and Chief Executive Officer

    No 10b5-1 plan16.2x usual sizeFiling

  8. 8 Form 4 sale Applied Therapeutics, Inc.Unusual
    Aug 14 +5 days

    Sold 777,014 shares at $6.06 ($4.7M)

    Shendelman Shoshana, President and CEO

    No 10b5-1 planSold 14.2% of holdings ($33.2M position)4.7M shares left12.6x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Shendelman Shoshana
Source
Aug 14, 2024Applied Therapeutics, Inc.President and CEOForm 4 sale777,014$4.7M14.2%UnusualSEC
Aug 9, 2024Applied Therapeutics, Inc.Officer, President and Chief Executive OfficerForm 144 notice1M$6.2MNoticeSEC
Jun 6, 2024Applied Therapeutics, Inc.President and CEOForm 4 sale61,795$267k1.6%No planSEC
Mar 14, 2024Applied Therapeutics, Inc.President and CEOForm 4 sale318,573$1.7M7.7%UnusualSEC
Nov 30, 2023Applied Therapeutics, Inc.President and CEOForm 4 sale3,968$8k0.2%No planSEC
Sep 27, 2023Applied Therapeutics, Inc.President and CEOForm 4 sale115,632$312k4.3%No planSEC
Jan 11, 2023Applied Therapeutics, Inc.President and CEOForm 4 sale15,870$14k2.1%Plan not statedSEC
Jul 22, 2020Applied Therapeutics, Inc.President and CEOForm 4 sale45,000$1.2M7.5%Plan not statedSEC
Jul 9, 2020Applied Therapeutics, Inc.President and CEOForm 4 sale45,000$1.4M7.5%Plan not statedSEC
May 28, 2020Applied Therapeutics, Inc.President and CEOForm 4 sale125,000$5.3M18.4%Plan not statedSEC